Vicore Pharma Holding AB listed its shares on Nasdaq and received drug designation from the United States Food and Drug Administration.
3 reports, 3 independent
Updated Sat 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vicore Pharma Holding AB listed its shares on Nasdaq and received drug designation from the United States Food and Drug Administration.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies Financial Group started coverage on Vicore Pharma shares.1 source
Vicore Pharma listed on Nasdaq and received FDA drug designation.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
United States Food and Drug Administration
agency of the US Department of Health and Human Services
Related events
- DiaMedica Therapeutics, Inc. shares were traded on the Nasdaq exchange on October 14, 2026.
- INmune Bio Inc. listed its shares on the stock exchange on July 9, 2026.
- Aaron was listed on the Nasdaq stock exchange today.
- Maase Inc. has been listed on the Nasdaq stock exchange.
- Regeneron Pharmaceuticals stock is traded on the Nasdaq exchange.